PL2976645T3 - Wsparcie decyzji klinicznej (cds) dla radioterapii raka prostaty - Google Patents

Wsparcie decyzji klinicznej (cds) dla radioterapii raka prostaty

Info

Publication number
PL2976645T3
PL2976645T3 PL14714384T PL14714384T PL2976645T3 PL 2976645 T3 PL2976645 T3 PL 2976645T3 PL 14714384 T PL14714384 T PL 14714384T PL 14714384 T PL14714384 T PL 14714384T PL 2976645 T3 PL2976645 T3 PL 2976645T3
Authority
PL
Poland
Prior art keywords
radiotherapy
cds
prostate cancer
decision support
clinical decision
Prior art date
Application number
PL14714384T
Other languages
English (en)
Inventor
Carolina Ribbing
Katrin Bitter
Original Assignee
Koninklijke Philips N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koninklijke Philips N.V. filed Critical Koninklijke Philips N.V.
Publication of PL2976645T3 publication Critical patent/PL2976645T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/10X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/103Treatment planning systems
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848Methods of protein analysis involving mass spectrometry
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/00584Control arrangements for automatic analysers
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01JELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
    • H01J49/00Particle spectrometers or separator tubes
    • H01J49/0027Methods for using particle spectrometers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/40Disorders due to exposure to physical agents, e.g. heat disorders, motion sickness, radiation injuries, altitude sickness, decompression illness
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/40ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
PL14714384T 2013-03-20 2014-03-07 Wsparcie decyzji klinicznej (cds) dla radioterapii raka prostaty PL2976645T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361803479P 2013-03-20 2013-03-20
EP14714384.6A EP2976645B1 (en) 2013-03-20 2014-03-07 Clinical decision support (cds) for radiotherapy in prostate cancer
PCT/IB2014/059526 WO2014147509A1 (en) 2013-03-20 2014-03-07 Clinical decision support (cds) for radiotherapy in prostate cancer

Publications (1)

Publication Number Publication Date
PL2976645T3 true PL2976645T3 (pl) 2017-12-29

Family

ID=50397207

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14714384T PL2976645T3 (pl) 2013-03-20 2014-03-07 Wsparcie decyzji klinicznej (cds) dla radioterapii raka prostaty

Country Status (7)

Country Link
US (1) US10828507B2 (pl)
EP (1) EP2976645B1 (pl)
JP (1) JP6381629B2 (pl)
CN (1) CN105051545B (pl)
PL (1) PL2976645T3 (pl)
RU (1) RU2015144692A (pl)
WO (1) WO2014147509A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3292494B1 (en) * 2015-05-05 2024-03-27 H. Lee Moffitt Cancer Center And Research Institute, Inc. Systems and methods for providing personalized radiation therapy
US11205127B2 (en) 2017-01-30 2021-12-21 International Business Machines Corporation Computer program product for sensory stimulation to ameliorate a cognitive state
WO2018187603A1 (en) * 2017-04-05 2018-10-11 Sensus Healthcare, Inc. Radiotherapy mobile and wireless device workflow management system
CN108061732B (zh) * 2018-01-18 2023-06-30 重庆工商大学 一种可穿戴式智能尿检系统及尿检方法
EP3705890A1 (en) 2019-03-06 2020-09-09 Institut Regional du Cancer de Montpellier In vitro method for assessing the risk of prostate side effect after treatment by ionizing radiation
EP3705891A1 (en) 2019-03-06 2020-09-09 Novagray In vitro method for assessing the risk of prostate side effect after treatment by ionizing radiation
CN110604550B (zh) * 2019-09-24 2022-06-21 广州医科大学附属肿瘤医院 一种肿瘤放疗后正常组织器官并发症预测模型的建立方法
EP3875608A1 (en) * 2020-03-05 2021-09-08 Koninklijke Philips N.V. Prediction of radiotherapy response for prostate cancer subject based on immune defense response genes

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ516848A (en) 1997-06-20 2004-03-26 Ciphergen Biosystems Inc Retentate chromatography apparatus with applications in biology and medicine
US20030207462A1 (en) 2002-01-25 2003-11-06 Ciphergen Biosystems, Inc. Monomers and polymers having energy absorbing moieties of use in desorption/ionization of analytes
US9342657B2 (en) * 2003-03-24 2016-05-17 Nien-Chih Wei Methods for predicting an individual's clinical treatment outcome from sampling a group of patient's biological profiles
EP2210099A4 (en) * 2007-03-27 2011-03-16 Vermillion Inc BIOMARKER FOR OVARIAL CARCINOMA
JP5476536B2 (ja) * 2007-10-03 2014-04-23 独立行政法人放射線医学総合研究所 乳癌の放射線治療による晩期副作用の発症を予測する方法
US8222616B2 (en) * 2007-10-25 2012-07-17 Tomotherapy Incorporated Method for adapting fractionation of a radiation therapy dose
CN102365111B (zh) * 2009-03-27 2016-06-22 皇家飞利浦电子股份有限公司 标志适配的正常组织并发症概率
CN102369530B (zh) * 2009-05-28 2016-05-18 皇家飞利浦电子股份有限公司 用于副作用预后和监测的装置
JP5785184B2 (ja) * 2009-12-10 2015-09-24 コーニンクレッカ フィリップス エヌ ヴェ 画像の医療データ及び非画像の医療データの両者の連続的な記憶及び統合された分析のための診断技術
US20140113388A1 (en) 2011-06-30 2014-04-24 Koninklijke Philips N.V. Treatment planning based on polypeptide radiotoxicity serum markers
TW201307847A (zh) * 2011-08-04 2013-02-16 Uropro Biotech Co Ltd 血清澱粉a用於評估放射線治療之方法及其用途

Also Published As

Publication number Publication date
CN105051545B (zh) 2018-03-02
CN105051545A (zh) 2015-11-11
EP2976645B1 (en) 2017-07-05
JP2016515700A (ja) 2016-05-30
RU2015144692A (ru) 2017-04-27
US20160008629A1 (en) 2016-01-14
WO2014147509A1 (en) 2014-09-25
JP6381629B2 (ja) 2018-08-29
EP2976645A1 (en) 2016-01-27
US10828507B2 (en) 2020-11-10

Similar Documents

Publication Publication Date Title
IL246067A0 (en) Classification of prostate cancer
IL245731A0 (en) Combined treatment for cancer
PL3967315T3 (pl) Akkermansia muciniphila do leczenia nowotworu złośliwego
DK3090062T3 (da) Fusionsgener associeret med fremadskridende prostatakræft
EP3046561A4 (en) Compounds for treating prostate cancer
IL237558A0 (en) Methods for the treatment of locally advanced breast cancer
EP3023101A4 (en) Therapeutic agent for fgfr inhibitor-resistant cancer
PL2976645T3 (pl) Wsparcie decyzji klinicznej (cds) dla radioterapii raka prostaty
GB201322725D0 (en) Cancer therapy
SG11201603050TA (en) Methods for treating cancers
SG11201510210XA (en) Methods for detecting prostate cancer
HUE045314T2 (hu) Kombinációs terápia rák kezelésére
EP3085380A4 (en) Composition for treating prostate cancer
SG11201509707QA (en) Cancer therapy
GB201322800D0 (en) Prostate cancer biomarkers
SG11201507847UA (en) Cancer therapy
IL244554A0 (en) Determination of recurrence of breast cancer
IL245037A0 (en) Treatment for pancreatic cancer
IL242551A (en) Expectation markers for cancer treatment
LT3016682T (lt) Vėžio gydymo būdai
IL238453A0 (en) Trans-clomiphene for use in cancer treatment
EP2961412A4 (en) CANCER THERAPY
EP3033617A4 (en) Biomarkers for prostate cancer
EP2934500A4 (en) COMBINATION THERAPY AGAINST CANCER
ZA201504169B (en) Anti-adam28 antibody for treating cancer